In lung cancer, the absence of integrin β3 allows OPN-a to stimulate cell growth via the CD44/NFκB pathway, and at high levels of integrin β3 OPN-a inhibits lung cancer cell growth [62]. This evidence concerns the gene CD44 and lung cancer.